ATE332364T1 - Verfahren zur gewinnung von purifizierter virenzuammensetzung - Google Patents
Verfahren zur gewinnung von purifizierter virenzuammensetzungInfo
- Publication number
- ATE332364T1 ATE332364T1 AT00906444T AT00906444T ATE332364T1 AT E332364 T1 ATE332364 T1 AT E332364T1 AT 00906444 T AT00906444 T AT 00906444T AT 00906444 T AT00906444 T AT 00906444T AT E332364 T1 ATE332364 T1 AT E332364T1
- Authority
- AT
- Austria
- Prior art keywords
- purified virus
- virus composition
- obtaining purified
- viral
- particles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10051—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9902167 | 1999-02-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE332364T1 true ATE332364T1 (de) | 2006-07-15 |
Family
ID=9542357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00906444T ATE332364T1 (de) | 1999-02-22 | 2000-02-21 | Verfahren zur gewinnung von purifizierter virenzuammensetzung |
Country Status (8)
Country | Link |
---|---|
US (1) | US7264958B1 (de) |
EP (1) | EP1155120B1 (de) |
JP (2) | JP4802366B2 (de) |
AT (1) | ATE332364T1 (de) |
AU (1) | AU774437B2 (de) |
CA (1) | CA2364934C (de) |
DE (1) | DE60029195T2 (de) |
WO (1) | WO2000050573A1 (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6383795B1 (en) | 1998-04-22 | 2002-05-07 | Genvec, Inc. | Efficient purification of adenovirus |
DK1407006T3 (da) * | 2001-12-20 | 2005-12-12 | Bavarian Nordic As | Fremgangsmåde til indvinding og oprensning af poxvirus fra inficerede celler |
WO2005014642A2 (en) | 2003-07-21 | 2005-02-17 | Transgene S.A. | Novel multifunctional cytokines |
EP1718738A2 (de) | 2004-02-23 | 2006-11-08 | Crucell Holland B.V. | Verfahren zur reinigung von viren |
CA2602944C (en) | 2005-04-11 | 2015-08-11 | Crucell Holland B.V. | Virus purification using ultrafiltration |
JP4670583B2 (ja) * | 2005-10-20 | 2011-04-13 | チッソ株式会社 | 水溶性カチオン性磁気微粒子を用いた脂質ベシクルの分離又は検出方法 |
CN101489655A (zh) | 2006-07-14 | 2009-07-22 | 威斯康星旧生研究基金会 | 捕获病毒用吸附膜 |
BRPI0806350A2 (pt) | 2007-01-30 | 2011-09-06 | Transgene Sa | uso de uma molécula de ácido nucléico, uso de um vetor, uso de um particula viral infecciosa, vetores, particula viral infecciosa e composição |
CA2742474C (en) | 2008-11-03 | 2016-05-31 | Crucell Holland B.V. | Method for the production of adenoviral vectors |
NZ593749A (en) | 2009-01-20 | 2012-05-25 | Transgene Sa | Soluble icam-1 as biomarker for prediction of therapeutic response |
US20120028279A1 (en) | 2009-03-24 | 2012-02-02 | Bruce Acres | Biomarker for monitoring patients |
BRPI1010512A2 (pt) | 2009-04-17 | 2016-03-15 | Transgène S A | "método ex vivo para avaliar a eficácia de um tratamento envolvendo a administração de uma composição imunogênica a um paciente, e, uso de níveis de linfócitos t ativados (cd3 + cd69+) como um biomarcador" |
DK2452194T3 (en) | 2009-07-10 | 2015-11-30 | Transgene Sa | Biomarker PATIENT SELECTION AND RELATED PRACTICES |
CA2770075C (en) | 2009-08-07 | 2021-08-24 | Perrine Martin | Composition for treating hbv infection |
DK2536829T3 (en) | 2010-02-15 | 2016-07-04 | Crucell Holland Bv | A process for the production of Ad26-adenovirus vectors |
CA2816190C (en) * | 2010-10-27 | 2020-03-24 | Philip Morris Products S.A. | Methods for capturing virus like particles from plants using expanded bed chromatography |
CN105821078A (zh) | 2010-12-09 | 2016-08-03 | 巴斯德研究所 | 用于获得高产量重组蛋白表达的基于mgmt的方法 |
TW201321016A (zh) | 2011-09-29 | 2013-06-01 | Transgene Sa | 免疫療法組成物及用於治療c型肝炎病毒感染之療程(二) |
WO2013045658A1 (en) | 2011-09-29 | 2013-04-04 | Transgene Sa | Immunotherapy composition and regimen for treating hepatitis c virus infection |
US10357555B2 (en) | 2012-07-10 | 2019-07-23 | Transgene Sa | Mycobacterial antigen vaccine |
WO2014009433A1 (en) | 2012-07-10 | 2014-01-16 | Transgene Sa | Mycobacterium resuscitation promoting factor for use as adjuvant |
WO2014066443A1 (en) | 2012-10-23 | 2014-05-01 | Emory University | Gm-csf and il-4 conjugates, compositions, and methods related thereto |
RS57043B1 (sr) | 2013-10-25 | 2018-05-31 | Psioxus Therapeutics Ltd | Onkolitički adenovirusi snabdeveni heterologus genima |
EP3092000A1 (de) | 2014-01-09 | 2016-11-16 | Transgene SA | Fusion von heterooligomeren mycobakteriellen antigenen |
WO2015196150A2 (en) | 2014-06-20 | 2015-12-23 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
WO2016131945A1 (en) | 2015-02-20 | 2016-08-25 | Transgene Sa | Combination product with autophagy modulator |
EA201891021A1 (ru) | 2015-12-17 | 2018-11-30 | Псайоксус Терапьютикс Лимитед | Аденовирус группы b, кодирующий антитело к комплексу tcr или фрагмент указанного антитела |
CA3023022A1 (en) | 2016-05-04 | 2017-11-09 | Transgene Sa | Combination therapy with cpg tlr9 ligand |
GB201713765D0 (en) | 2017-08-28 | 2017-10-11 | Psioxus Therapeutics Ltd | Modified adenovirus |
US20190328869A1 (en) | 2016-10-10 | 2019-10-31 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
JP7078620B2 (ja) | 2016-11-16 | 2022-05-31 | イミュノミック セラピューティックス, インコーポレイテッド | アレルギーの治療のための核酸 |
WO2018195527A1 (en) | 2017-04-22 | 2018-10-25 | Immunomic Therapeutics, Inc. | Improved lamp constructs |
KR20240027895A (ko) | 2017-05-02 | 2024-03-04 | 이뮤노믹 쎄라퓨틱스, 인크. | 암 항원을 포함하는 lamp (리소솜 연관 막 단백질) 구축물 |
GB201801614D0 (en) | 2018-01-31 | 2018-03-14 | Psioxus Therapeutics Ltd | Formulation |
JP2021523185A (ja) | 2018-05-15 | 2021-09-02 | イミュノミック セラピューティックス, インコーポレイテッドImmunomic Therapeutics, Inc. | アレルゲンを含む改善されたlamp構築物 |
US20210290754A1 (en) * | 2018-08-07 | 2021-09-23 | Wisconsin Alumni Research Foundation (Warf) | Recombinant biologically contained filovirus vaccine |
US20220008888A1 (en) * | 2018-11-22 | 2022-01-13 | Fixed Phage Limited | Production of immobilised bacteriophage |
TW202043256A (zh) | 2019-01-10 | 2020-12-01 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
US11851648B2 (en) | 2019-02-08 | 2023-12-26 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
GB201909081D0 (en) * | 2019-06-25 | 2019-08-07 | Psioxus Therapeutics Ltd | Method |
EP4022046A2 (de) | 2019-08-27 | 2022-07-06 | Wisconsin Alumni Research Foundation (WARF) | Rekombinante influenzaviren mit stabilisiertem ha zur replikation in eiern |
AU2020366515A1 (en) | 2019-10-18 | 2022-04-21 | Immunomic Therapeutics, Inc. | Improved lamp constructs comprising cancer antigens |
WO2021099906A1 (en) | 2019-11-18 | 2021-05-27 | Janssen Biotech, Inc. | Vaccines based on mutant calr and jak2 and their uses |
TW202144388A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在卵巢癌中表現之新抗原及其用途 |
TW202144389A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在多發性骨髓瘤中表現之新抗原及其用途 |
US20210315986A1 (en) | 2020-04-13 | 2021-10-14 | Janssen Biotech, Inc. | Psma and steap1 vaccines and their uses |
US20230035403A1 (en) | 2020-07-06 | 2023-02-02 | Janssen Biotech, Inc. | Method For Determining Responsiveness To Prostate Cancer Treatment |
US20230024133A1 (en) | 2020-07-06 | 2023-01-26 | Janssen Biotech, Inc. | Prostate Neoantigens And Their Uses |
US20230029453A1 (en) | 2020-07-06 | 2023-02-02 | Janssen Biotech, Inc. | Prostate Neoantigens And Their Uses |
WO2023201201A1 (en) | 2022-04-10 | 2023-10-19 | Immunomic Therapeutics, Inc. | Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0328256A1 (de) * | 1988-01-21 | 1989-08-16 | Owens-Corning Fiberglas Corporation | Glasfaser, überzogen mit Agarose, zur Verwendung als Säulenpackung oder chromatographisches Medium in Biotrennungen |
GB8806605D0 (en) | 1988-03-19 | 1988-04-20 | Robinson E | Composite adsorbents |
SE9101149D0 (sv) | 1991-04-17 | 1991-04-17 | Pharmacia Lkb Biotech | Beads for down stream processing |
DE4128953A1 (de) | 1991-08-30 | 1993-03-04 | Basf Ag | Verfahren zur kultivierung von saeugerzellen im fliessbettreaktor |
US5837520A (en) * | 1995-03-07 | 1998-11-17 | Canji, Inc. | Method of purification of viral vectors |
FR2737730B1 (fr) * | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
AU722196B2 (en) | 1995-08-30 | 2000-07-27 | Genzyme Corporation | Chromatographic purification of adenovirus and AAV |
AU2660397A (en) * | 1996-04-05 | 1997-10-29 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells |
CZ438398A3 (cs) | 1996-07-01 | 1999-03-17 | Rhone-Poulenc Rorer S. A. | Způsob přípravy rekombinantních adenovirů |
AU732703B2 (en) | 1996-11-20 | 2001-04-26 | Crucell Holland B.V. | An improved method for the production and purification of adenoviral vectors |
DE69739961D1 (de) | 1996-12-13 | 2010-09-23 | Schering Corp | Methoden zur Virus-Reinigung |
SE9700383D0 (sv) * | 1997-02-04 | 1997-02-04 | Pharmacia Biotech Ab | An adsorption/separation method and a medium for adsorption/separation |
WO1999040702A1 (en) | 1998-02-04 | 1999-08-12 | Sun Microsystems, Inc. | Method and apparatus for efficient authentication and integrity checking using hierarchical hashing |
US6383795B1 (en) | 1998-04-22 | 2002-05-07 | Genvec, Inc. | Efficient purification of adenovirus |
-
2000
- 2000-02-21 DE DE60029195T patent/DE60029195T2/de not_active Expired - Lifetime
- 2000-02-21 EP EP00906444A patent/EP1155120B1/de not_active Expired - Lifetime
- 2000-02-21 AT AT00906444T patent/ATE332364T1/de active
- 2000-02-21 JP JP2000601137A patent/JP4802366B2/ja not_active Expired - Lifetime
- 2000-02-21 WO PCT/FR2000/000430 patent/WO2000050573A1/fr active Search and Examination
- 2000-02-21 CA CA2364934A patent/CA2364934C/fr not_active Expired - Lifetime
- 2000-02-21 AU AU28118/00A patent/AU774437B2/en not_active Expired
- 2000-02-21 US US09/914,036 patent/US7264958B1/en not_active Expired - Lifetime
-
2011
- 2011-01-20 JP JP2011009922A patent/JP2011120596A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1155120A1 (de) | 2001-11-21 |
CA2364934A1 (fr) | 2000-08-31 |
JP2011120596A (ja) | 2011-06-23 |
DE60029195T2 (de) | 2007-06-28 |
CA2364934C (fr) | 2011-10-18 |
JP2002536992A (ja) | 2002-11-05 |
DE60029195D1 (de) | 2006-08-17 |
JP4802366B2 (ja) | 2011-10-26 |
US7264958B1 (en) | 2007-09-04 |
AU774437B2 (en) | 2004-06-24 |
AU2811800A (en) | 2000-09-14 |
EP1155120B1 (de) | 2006-07-05 |
WO2000050573A1 (fr) | 2000-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE332364T1 (de) | Verfahren zur gewinnung von purifizierter virenzuammensetzung | |
ATE324436T1 (de) | Verfahren zur reinigung von menschlichen, dem papillomavirus ähnlichen partikeln. | |
ATE306252T1 (de) | Verfahren zur herstellung kristalliner partikel zur inhalation | |
DE60221619D1 (de) | Verfahren zur Reinigung von Synthesegas | |
DE69908998D1 (de) | Verfahren zur Herstellung von Kohlenstoff | |
DE69703957T2 (de) | Verfahren zur Herstellung von kristallinen Ceroxidteilchen. | |
DE69807962T2 (de) | Verfahren zur Reinigung von rohem 1,1,1,3,3-Pentafluorpropan | |
ATE278785T1 (de) | Neues verfahren zur gewinnung und reinigung von fusionsproteinen | |
DE69637509D1 (de) | Verfahren zur reinigung von faktor-ix | |
DE60132094D1 (de) | Verfahren zur Herstellung von gereinigten Partikeln | |
ATE322252T1 (de) | Verfahren zur herstellung und sammlung von kristallinen partikeln | |
DE60120819D1 (de) | Verfahren zur adsorptiven Trennung von Kohlendioxid | |
DE60114348D1 (de) | Verfahren zur Reinigung von Gasen | |
DE60212062D1 (de) | Verfahren zur Herstellung von porösen Polyesterpartikeln | |
DE60330146D1 (de) | Verfahren zur reinigung von fibrinogen | |
DE60203975D1 (de) | Verfahren zur Herstellung von magnetischen Teilchen, magnetische Teilchen und magnetischer Werkstoff | |
AU2003279240A1 (en) | Methods for purifying viral particles for gene therapy | |
DE69531308D1 (de) | Verfahren zur Herstellung von gereinigten papillomavirus Proteinen | |
DE60105209D1 (de) | Verfahren zur Herstellung von niedrig substituierter Hydroxypropylcellulose-Partikeln | |
DE69931976D1 (de) | Verfahren zur Herstellung von Aminophosphinen und Aminophosphinoxiden, Zwischenprodukte dafür | |
DE69300901D1 (de) | Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan. | |
DE60002020D1 (de) | Verfahren zur Herstellen von hochreinem Xylitol | |
DE69709303D1 (de) | Verfahren zur Synthese von Diamant | |
AU2003265052A1 (en) | Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby | |
DE59912502D1 (de) | Verfahren zur herstellung von enantiomerenreinem n-methyl- n- (1s)- 1-phenyl- 2-((3s)-3- hydroxypyrrolidin- 1-yl)ethyl]- 2,2- diphenylacetamid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1155120 Country of ref document: EP |